Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease.
Sign Up to like & getrecommendations! Published in 2021 at "CNS spectrums"
DOI: 10.1017/s1092852920002618
Abstract: BACKGROUND In the First-HD pivotal trial, the maximum deutetrabenazine dose evaluated to treat chorea associated with Huntington's disease (HD chorea) was 48 mg/d, which is the approved maximum dose for this population. In ARC-HD, an… read more here.
Keywords: safety deutetrabenazine; huntington disease; deutetrabenazine; treat chorea ... See more keywords